SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-066564
Filing Date
2024-05-30
Accepted
2024-05-30 16:05:22
Documents
16
Period of Report
2024-07-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A eldn-20240530.htm   iXBRL DEF 14A 1202917
2 GRAPHIC img117103358_0.jpg GRAPHIC 191772
3 GRAPHIC img117103358_1.jpg GRAPHIC 143022
4 GRAPHIC img117103358_2.jpg GRAPHIC 140421
5 GRAPHIC img117103358_3.jpg GRAPHIC 936544
6 GRAPHIC img117103358_4.jpg GRAPHIC 520524
  Complete submission text file 0000950170-24-066564.txt   6476954

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eldn-20240530.xsd EX-101.SCH 21699
19 EXTRACTED XBRL INSTANCE DOCUMENT eldn-20240530_htm.xml XML 308283
Mailing Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612
Business Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36620 | Film No.: 241005175
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)